查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571627

中風治療市場規模、佔有率和趨勢分析報告：按類型、藥物類別、分銷管道、地區和細分市場預測，2024-2030

Cerebral Infarction Treatment Market Size, Share & Trends Analysis Report By Type (Chemotherapy), By Drug Class (Oral), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

中風治療市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球中風治療市場規模預計將達到205億美元，複合年成長率為7.3%。

由於世界人口老化導致缺血性中風盛行率不斷上升，以及高血壓和糖尿病等與生活方式相關的危險因子增加，是推動中風治療市場擴大的關鍵因素。

根據美國國家醫學圖書館2023年3月發表的研究，每年出血性中風佔所有中風的10.0%至20.0%。不同地區的發生率差異很大，美國、英國和澳洲為 8.0% 至 15.0%，日本和韓國為 18.0% 至 24.0%。低收入和中等收入國家以及亞洲人群中出血性中風的發生率明顯較高。此外，男性中風的發生率較高，並且隨著年齡的成長而增加，而全球出血性中風的負擔正在增加，特別是在非洲和亞洲國家。儘管有效的高血壓管理已被證明可以降低腦出血（ICH）的發生率，但死亡率仍令人擔憂，高所得國家的死亡率為25.0% 至30.0%，低收入地區為30% 至48% 。

技術進步顯著改善了中風的治療狀況。組織胞漿素原原活化劑 (tPA) 等溶栓療法的創新和機械血栓切除裝置的開發顯著改善了患者的治療效果。此外，人工智慧（AI）融入診斷和治療過程正在徹底改變中風治療。人工智慧主導的演算法現在在預測中風風險和客製化治療策略方面發揮關鍵作用，有助於個人化治療並提高整體效果。這些進步不僅提高了治療精度，而且有助於先進治療方法的廣泛採用。這些技術進步，加上研發投資的增加，預計將推動中風治療市場的顯著成長。

中風治療市場報告亮點

  • 2023年，由於其盛行率高、技術進步以及早期療育意識增強，缺血性腦中風領域佔最大佔有率，達78.6%。
  • 組織胞漿素原活化劑（tPA）細分市場由於其經過驗證的功效、廣泛使用以及在缺血性中風治療中的重要作用，在 2023 年佔據了最大的收益佔有率，達到 39.7%。
  • 2023年，醫院藥局部門在中風治療市場佔據主導地位，佔了63.6%的巨大收益佔有率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章中風治療市場的變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 中風治療市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章中風治療市場：依治療方法估算與趨勢分析

  • 全球中風治療市場儀表板：依治療分類
  • 全球中風治療市場波動分析：依治療方式
  • 全球中風治療市場收益：依治療分類
  • 缺血性中風
  • 出血性中風

第5章中風治療市場：依藥物類別估算與趨勢分析

  • 全球中風治療市場儀表板：依藥物類別
  • 全球中風治療市場波動分析：依藥物類別
  • 收益：按藥物類別
  • 組織胞漿素原原活化劑
  • 抗凝血物
  • 抗血小板藥
  • 抗凝血物
  • 其他

第6章中風治療市場：按通路估計和趨勢分析

  • 全球中風治療市場儀表板：按分銷管道
  • 全球中風治療市場波動分析：按分銷管道
  • 收益：按分銷管道分類
  • 醫院藥房
  • 零售藥房
  • 其他

第7章中風治療市場：依地區估算及趨勢分析

  • 儀表板：依地區
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭格局

  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • Key company market share analysis, 2023
    • Amgen Inc.
    • Pfizer Inc.
    • Novartis AG
    • Amneal Pharmaceuticals LLC
    • Sanofi
    • Abbott Laboratories
    • Johnson &Johnson
    • Bristol-Myers Squibb
Product Code: GVR-4-68040-450-8

Cerebral Infarction Treatment Market Growth & Trends:

The global cerebral infarction treatment market size is expected to reach USD 20.5 billion by 2030 and is projected to grow at a CAGR of 7.3%, according to a new report by Grand View Research, Inc. The growing prevalence of ischemic strokes, driven by an aging global population and increasing rates of lifestyle-related risk factors such as hypertension and diabetes, is a key factor in the expansion of the cerebral infarction treatment market.

According to a study published by the National Library of Medicine in March 2023, hemorrhagic stroke accounts for 10.0% to 20.0% of all strokes annually. The incidence varies significantly by region, with 8.0%-15.0% in the U.S., the UK, and Australia, and 18.0% to 24.0% in Japan and Korea. The rate of hemorrhagic stroke is notably higher in low- and middle-income countries, and among Asians. Furthermore, while stroke incidence is higher in men and increases with age, the global burden of hemorrhagic stroke is rising, particularly in African and Asian countries. Effective management of hypertension has been shown to reduce the incidence of intracerebral hemorrhage (ICH), though the fatality rate remains a concern, ranging from 25.0% to 30.0% in high-income countries and 30% to 48% in lower-income regions, highlighting disparities in critical care efficacy.

Technological advancements are significantly enhancing the treatment landscape for cerebral infarction. Innovations in thrombolytic therapies, such as tissue plasminogen activators (tPA), and development of mechanical thrombectomy devices have markedly improved patient outcomes. Moreover, the integration of artificial intelligence (AI) into diagnostic and treatment processes is revolutionizing stroke care. AI-driven algorithms now play a crucial role in predicting stroke risk and tailoring treatment strategies, which helps in personalizing care and improving overall efficacy. These advancements are not only improving the precision of treatments but also contributing to the broader adoption of advanced therapeutic options. Combined with increased investment in research and development, these technological strides are expected to drive significant growth in the cerebral infarction treatment market.

Cerebral Infarction Treatment Market Report Highlights:

  • In 2023, the ischemic stroke segment held the largest share of 78.6% due to its high prevalence, technological advancements, and growing awareness of early intervention
  • The tissue plasminogen activators (tPA) segment secured the largest revenue share of 39.7% in 2023, driven by its proven efficacy, widespread use, and crucial role in treating ischemic strokes
  • In 2023, the hospital pharmacies segment dominated the cerebral infarction treatment market, capturing a substantial revenue share of 63.6%

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Drug Class
    • 1.2.3. Distribution Channel
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Drug Class
    • 2.2.3. Distribution Channel
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cerebral Infarction Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising Prevalence Cerebrovascular Diseases
      • 3.2.1.2. Advancements In Medical Technology
      • 3.2.1.3. Aging Global Population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Treatment and Devices
      • 3.2.2.2. Strict Regulatory Approvals
  • 3.3. Cerebral Infarction Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Cerebral Infarction Treatment Market: Treatment Estimates & Trend Analysis

  • 4.1. Global Cerebral Infarction Treatment Market: Treatment Dashboard
  • 4.2. Global Cerebral Infarction Treatment Market: Treatment Movement Analysis
  • 4.3. Global Cerebral Infarction Treatment Market by Treatment , Revenue
  • 4.4. Ischemic Stroke
    • 4.4.1. Ischemic stroke market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Hemorrhagic stroke
    • 4.5.1. Hemorrhagic stroke market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cerebral Infarction Treatment Market: Drug Class Estimates & Trend Analysis

  • 5.1. Global Cerebral Infarction Treatment Market: Drug Class Dashboard
  • 5.2. Global Cerebral Infarction Treatment Market: Drug Class Movement Analysis
  • 5.3. Global Cerebral Infarction Treatment Market Estimates and Forecasts, By Drug Class, Revenue (USD Million)
  • 5.4. Tissue Plasminogen Activators
    • 5.4.1. Tissue Plasminogen Activators market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Anticoagulants
    • 5.5.1. Anticoagulants market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Antiplatelets
    • 5.6.1. Antiplatelets market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Anticoagulants
    • 5.7.1. Anticoagulants market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cerebral Infarction Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Global Cerebral Infarction Treatment Market: Distribution Channel Dashboard
  • 6.2. Global Cerebral Infarction Treatment Market: Distribution Channel Movement Analysis
  • 6.3. Global Cerebral Infarction Treatment Market Estimates and Forecasts, By Distribution Channel, Revenue (USD Million)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Hospital Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Retail Pharmacies
    • 6.5.1. Retail Pharmacies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cerebral Infarction Treatment Market: Regional Estimates & Trend Analysis by Treatment, Drug Class, and Distribution Channel

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Vendor Landscape
    • 8.2.1. List of key distributors and channel partners
    • 8.2.2. Key company market share analysis, 2023
    • 8.2.3. Amgen Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Pfizer Inc.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Novartis AG
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Amneal Pharmaceuticals LLC
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Sanofi
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Abbott Laboratories
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Johnson & Johnson
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Bristol-Myers Squibb
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List Of Abbreviation
  • Table 2 North America Cerebral Infarction Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 4 North America Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 5 North America Cerebral Infarction Treatment Market, Distribution Channel, 2018 - 2030 (USD Million)
  • Table 6 U.S. Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 8 U.S. Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9 Canada Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 Canada Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 11 Canada Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 12 Mexico Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 Mexico Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 14 Mexico Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 15 Europe Cerebral Infarction Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 16 Europe Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 Europe Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 18 Europe Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Germany Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 20 Germany Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 21 Germany Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 22 UK Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 UK Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 24 UK Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 25 France Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 France Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 27 France Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 28 Italy Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 Italy Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 30 Italy Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 31 Spain Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 Spain Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 33 Spain Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 Denmark Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Denmark Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 36 Denmark Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 37 Sweden Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 Sweden Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 39 Sweden Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 40 Norway Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 Norway Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 42 Norway Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Cerebral Infarction Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 China Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 China Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 49 China Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 50 Japan Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Japan Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 52 Japan Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 53 India Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 India Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 55 India Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 56 South Korea Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 57 South Korea Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 58 South Korea Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 59 Australia Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 Australia Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 61 Australia Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 62 Thailand Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 Thailand Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 64 Thailand Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 65 Latin America Cerebral Infarction Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 66 Latin America Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 67 Latin America Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 68 Latin America Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Brazil Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 70 Brazil Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 71 Brazil Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 72 Argentina Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 Argentina Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 74 Argentina Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 75 MEA Cerebral Infarction Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 76 MEA Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 77 MEA Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 78 MEA Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 South Africa Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 80 South Africa Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 81 South Africa Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 85 UAE Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 86 UAE Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 87 UAE Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Cerebral Infarction Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Cerebral Infarction Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Cerebral Infarction Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Cerebral Infarction Treatment Market: Market Outlook
  • Fig. 14 Cerebral Infarction Treatment Competitive Insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Cerebral Infarction Treatment Market Driver Impact
  • Fig. 18 Cerebral Infarction Treatment Market Restraint Impact
  • Fig. 19 Cerebral Infarction Treatment Market Strategic Initiatives Analysis
  • Fig. 20 Cerebral Infarction Treatment Market: Treatment Movement Analysis
  • Fig. 21 Cerebral Infarction Treatment Market: Treatment Outlook and Key Takeaways
  • Fig. 22 Ischemic Stroke market estimates and forecast, 2018 - 2030
  • Fig. 23 Hemorrhagic Stroke market estimates and forecast, 2018 - 2030
  • Fig. 24 Cerebral Infarction Treatment Market: Drug Class Movement Analysis
  • Fig. 25 Cerebral Infarction Treatment Market: Drug Class Outlook and Key Takeaways
  • Fig. 26 Tissue Plasminogen Activators market estimates and forecast, 2018 - 2030
  • Fig. 27 Anticoagulants market estimates and forecast, 2018 - 2030
  • Fig. 28 Antiplatelets market estimates and forecast, 2018 - 2030
  • Fig. 29 Anticonvulsants market estimates and forecast, 2018 - 2030
  • Fig. 30 Others market estimates and forecast, 2018 - 2030
  • Fig. 31 Cerebral Infarction Treatment Market: Distribution Channel Movement Analysis
  • Fig. 32 Cerebral Infarction Treatment Market: Distribution Channel Outlook and Key Takeaways
  • Fig. 33 Hospital pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 34 Retail pharmacies market estimates and forecast, 2018 - 2030
  • Fig. 35 Other market estimates and forecast, 2018 - 2030
  • Fig. 36 Global Cerebral Infarction Treatment Market: Regional Movement Analysis
  • Fig. 37 Global Cerebral Infarction Treatment Market: Regional Outlook and Key Takeaways
  • Fig. 38 Global Cerebral Infarction Treatment market share and leading players
  • Fig. 39 North America, by country
  • Fig. 40 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. key country dynamics
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Canada key country dynamics
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Mexico key country dynamics
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UK key country dynamics
  • Fig. 49 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Germany key country dynamics
  • Fig. 51 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 France key country dynamics
  • Fig. 53 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Italy key country dynamics
  • Fig. 55 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Spain key country dynamics
  • Fig. 57 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Denmark key country dynamics
  • Fig. 59 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Sweden key country dynamics
  • Fig. 61 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Norway key country dynamics
  • Fig. 63 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 China key country dynamics
  • Fig. 66 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Japan key country dynamics
  • Fig. 68 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 India key country dynamics
  • Fig. 70 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Thailand key country dynamics
  • Fig. 72 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 South Korea key country dynamics
  • Fig. 74 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Australia key country dynamics
  • Fig. 76 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Brazil key country dynamics
  • Fig. 79 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Argentina key country dynamics
  • Fig. 81 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 South Africa key country dynamics
  • Fig. 84 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Saudi Arabia key country dynamics
  • Fig. 86 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 UAE key country dynamics
  • Fig. 88 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Kuwait key country dynamics
  • Fig. 90 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Market share of key market players - Cerebral Infarction Treatment market